J. Laporte

发表

Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels

T. Walley, U. Lindblad, T. Klaukka, 2006, Diabetologia.

Health needs, drug registration and control in less developed countries—the Peruvian case

Albert Figueras, J. Laporte, Susana Vásquez, 2002, Pharmacoepidemiology and drug safety.

Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials.

X. Vidal, S Bonet, A Agustí, 2000, Archives of internal medicine.

Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine.

D. Capellà, J. Castel, J. Laporte, 1988, BMJ.

Separating the wheat from the chaff: essential information in therapeutics

Albert Figueras, J. Laporte, M. Bosch, 2011, European Journal of Clinical Pharmacology.

Upper Gastrointestinal Bleeding Associated with the Use of NSAIDs

R. Leone, X. Vidal, L. Ibañez, 2004, Drug safety.

Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease.

X. Vidal, L. Ibañez, J. Laporte, 2005, Kidney international.

Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. The Venous Thromboembolism Study Group of the Spanish Society of Clinical Pharmacology.

J. Laporte, A. Vallano, J. Vallés, 1994, British journal of clinical pharmacology.

Impact of analgesic drug-use guidelines for the management of postoperative pain: a drug utilization study.

L. Girona, A. Vallano, J. Laporte, 2003, International journal of clinical pharmacology and therapeutics.

Treatment of Type 2 Diabetes in Primary Health Care: A Drug Utilization Study

D. Amato, Albert Figueras, J. Laporte, 2005, The Annals of pharmacotherapy.

Agranulocytosis induced by nonchemotherapy drugs.

X. Vidal, L. Ibañez, J. Laporte, 2008, Annals of internal medicine.

Sources of European drug consumption data at a country level

J. Hasford, I. Tatt, L. Ibañez, 2014, International Journal of Public Health.

Utilization of antihypertensive drugs in certain European countries

M. Porta, D. Capellà, J. Laporte, 2004, European Journal of Clinical Pharmacology.

Multicenter study on self‐medication and self‐prescription in six Latin American countries

J. Castel, J. Laporte, J. Orozco, 1997, Clinical pharmacology and therapeutics.

Case-Population Studies in Pharmacoepidemiology

X. Vidal, D. Capellà, J. Laporte, 2002, Drug safety.

Calcitonin and epistaxis

D. Capellà, Albert Figueras, J. Laporte, 1994 .

Migraine and other headaches : Associations with Rose angina and coronary heart disease. Author's reply

W. Landau, E. Montané, J. Laporte, 2005 .

b -Adrenergic Blocking Agents in Heart Failure Benefits of Vasodilating and Nonvasodilating Agents According to Patients’ Characteristics: A Meta-analysis of Clinical Trials

X. Vidal, E. Galve, E. Diògene, 2000 .

EFFECTS OF DIOXIN EXPOSURE

J. Laporte, K. Crow, 1977, The Lancet.

Management of postoperative pain in abdominal surgery in Spain. A multicentre drug utilization study.

J. Baños, J. Laporte, A. Vallano, 1999, British journal of clinical pharmacology.

Nightmares induced by montelukast in children and adults

J. Laporte, N. García Doladé, G. Cereza, 2012, European Respiratory Journal.

Bovine gangliosides and acute motor polyneuropathy.

D. Capellà, Albert Figueras, J. Laporte, 1992, BMJ.

Regulatory Decisions in a Globalised World

Albert Figueras, J. Laporte, 2002, Drug safety.

Sales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007–2010

L. Ibañez, S. Schmiedl, M. Rottenkolber, 2015, SpringerPlus.

Patterns of use of psychotropic drugs in Spain in an international perspective

M. Porta, D. Capellà, J. Laporte, 1983 .

Therapeutic consultation: a necessary adjunct to independent drug information.

X. Vidal, J. Laporte, J. Arnau, 1993, British journal of clinical pharmacology.

Developing National Systems: Spain as a Model

J. Laporte, 1985 .

Drugs in the Spanish Health System

M. Porta, D. Capellà, J. Laporte, 1984, International journal of health services : planning, administration, evaluation.

Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.

A. Pastor, M. Farré, X. Vidal, 2010, British journal of clinical pharmacology.

Drug utilization studies: a tool for determining the effectiveness of drug use.

M. Porta, D. Capellà, J. Laporte, 1983, British journal of clinical pharmacology.

Drug Prescribing and Use among Elderly People in Spain

D. Capellà, L. Ibañez, J. Laporte, 1983, Drug intelligence & clinical pharmacy.

Use of heparin for the prevention of venous thromboembolism

R. Gracia, J. Laporte, A. Vallano, 1994 .

Combined Methylxanthines and Beta-Adrenergic Agonists in the Treatment of Severe Asthma

F. Morell, J. de Gracia, J. Laporte, 1983, Drug intelligence & clinical pharmacy.

[Cough caused by angiotensin-converting enzyme inhibitors. A series of cases collected by spontaneous notification of adverse reactions].

D. Capellà, J. Laporte, F. Torres, 1991, Medicina clinica.

Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series

M. Buti, X. Vidal, R. Solá, 2011, BMC gastroenterology.

Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter A double-blind, randomized, placebo-controlled trial

M. Vilardell, M. Bleda, C. Vallvé, 1999, European Journal of Clinical Pharmacology.

Amiodarone and pulmonary fibrosis

J. Ruiz, J. Morera, F. Morell, 2004, European Journal of Clinical Pharmacology.

USELESS DRUGS ARE NOT PLACEBOS

D. Capellà, J. Laporte, 1987, The Lancet.

Cross-National comparison of antiepileptic drug use: Catalonia, Denmark and Norway, 2007-2011

F. Rossi, A. Capuano, L. Ibañez, 2014, Epidemiology, Biostatistics, and Public Health.

New drugs, new adverse drug reactions, and bibliographic databases

Albert Figueras, J. Laporte, F. Estévez, 1999, The Lancet.

β-Adrenergic Blocking Agents in Heart Failure: Benefits of Vasodilating and Nonvasodilating Agents According to Patients' Characteristics: A Meta-analysis of Clinical Trials

Eduard Diogène, X. Vidal, E. Galve, 2000 .

Post-marketing surveillance

X. Carné, D. Capellà, J. Laporte, 1988 .

Agranulocytosis associated with calcium dobesilate

X. Vidal, L. Ibañez, J. Laporte, 2000, European Journal of Clinical Pharmacology.

Dysgeusia and burning mouth syndrome by eprosartan

X. Castells, J. Laporte, C. Pedrós, 2002, BMJ : British Medical Journal.

PHARMACOEPIDEMIOLOGY AND PRESCRIPTION

X. Vidal, L. Ibañez, J. Laporte, 2005 .

A randomized, double-blind, placebo-controlled trial comparing pethidine to metamizol for treatment of post-anaesthetic shivering.

J. Laporte, J. Arnau, A. Monsó, 2003, British journal of clinical pharmacology.

Risk of acute liver injury associated with the use of drugs: a multicentre population survey

M. Buti, X. Vidal, R. Solá, 2007, Alimentary pharmacology & therapeutics.

[The Spanish drug surveillance system].

D. Capellà, J. Laporte, 1994, Medicina clinica.

WHICH SALT OF ERYTHROMYCIN IS MOST HEPATOTOXIC?

D. Capellà, J. Laporte, V. Moreno, 1988, The Lancet.

Bronchospasm induced by royal jelly

L. Ibañez, J. Laporte, E. Ballarín, 1996, Allergy.

From clinical trials to usual practice: efficacy and effectiveness in clinical pharmacology.

J. Laporte, 1999, Methods and findings in experimental and clinical pharmacology.

Adverse Drug Reactions Leading to Hospital Admission

X. Carné, L. Ibañez, J. Laporte, 1991, Drug safety.

Epidemiology of aplastic anemia: a prospective multicenter study

X. Vidal, E. Montané, L. Ibañez, 2008, Haematologica.

[The physician and self medication].

J. Castel, J. Laporte, 1992, Medicina clinica.

An Epidemiologic Study of Severe Anaphylactic and Anaphylactoid Reactions among Hospital Patients: Methods and Overall Risks The International Collaborative Study of Severe Anaphylaxis

Theresa Anderson, Lars Alfredsson, S. Shapiro, 1998, Epidemiology.

Population-based drug-induced agranulocytosis.

X. Vidal, L. Ibañez, J. Laporte, 2005, Archives of internal medicine.

Upper Gastrointestinal Bleeding Associated with the Use of NSAIDs Newer Versus Older Agents

R. Leone, X. Vidal, L. Ibañez, 2004 .

BLOOD DYSCRASIAS AND THE RELATIVE SAFETY OF NON-NARCOTIC ANALGESICS

X. Carné, J. Laporte, 1987, The Lancet.

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data.

J. Matthews, M. Rawlins, S. Lewis, 2002, British journal of clinical pharmacology.

Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database

J. Laporte, N. Escoda, C. Asensio, 2018, Drug Safety.

[The decree on selective drug financing in charge of the Social Security].

J. Laporte, J. Arnau, 1993, Medicina clinica.

Fifty years of pharmacovigilance – Medicines safety and public health

J. Laporte, 2016, Pharmacoepidemiology and drug safety.

Therapeutic consultation centres are helpful in developing countries

Albert Figueras, J. Laporte, 2002, BMJ : British Medical Journal.

USELESS DRUGS ARE NOT PLACEBOS: LESSONS FROM FLUNARIZINE AND CINNARIZINE

D. Capellà, J. Laporte, 1986, The Lancet.

Drug utilization in Latin America- the example of DURG-LA

H. Buschiazzo, J. Laporte, A. Figueras, 2003 .

Rifampicin in tuberculous meningitis: A retrospective assessment

M. Gallofré, J. Massons, J. Laporte, 2004, European Journal of Clinical Pharmacology.

Relative incidence of agranulocytosis and aplastic anemia

S. Shapiro, N. Young, D. Kaufman, 2006, American journal of hematology.

Fluoxetine-induced hepatitis: why is postmarketing surveillance needed?

D. Capellà, Albert Figueras, J. Laporte, 1999, European Journal of Clinical Pharmacology.

[Self medication: does information to users increase at the same rate as consumption].

J. Laporte, 1997, Medicina clínica (Ed. impresa).

Adverse Effects of ACE Inhibitors in Patients with Chronic Heart Failure and/or Ventricular Dysfunction

X. Vidal, A. Agustí, J. Laporte, 2003, Drug safety.

Topiramate in non-approved indications and acute myopia or angle closure glaucoma.

J. Laporte, C. Pedrós, G. Cereza, 2005, British journal of clinical pharmacology.

The Cuban experience in focusing pharmaceuticals policy to health population needs: initial results of the National Pharmacoepidemiology Network (1996–2001)

E. Diògene, Albert Figueras, J. Laporte, 2003, Pharmacoepidemiology and drug safety.

The Case-Population Study Design

N. Moore, B. Bégaud, J. Laporte, 2011, Drug safety.

Caffeine, tobacco, alcohol and drug consumption among medical students in Barcelona

J. Camí, J. Laporte, J. Laporte, 1977, European Journal of Clinical Pharmacology.

Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants

X. Vidal, A. Conforti, L. Ibañez, 2008, Drug safety.

Spontaneous reporting of adverse drug reactions in Cuba: integrating continuous education, training and research in a network approach.

E. Diògene, Albert Figueras, J. Laporte, 2002, British journal of clinical pharmacology.

Oral antispastic drugs in nonprogressive neurologic diseases

E. Montané, J. Laporte, A. Vallano, 2004, Neurology.

Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs.

X. Vidal, L. Ibañez, J. Laporte, 2002, Journal of hepatology.

syndrome by eprosartan Drug points: Dysgeusia and burning mouth

X. Castells, J. Laporte, C. Pedrós, 2007 .

Proton Pump Inhibitors and Risk of Upper Gastrointestinal Bleeding in NSAID Users

X. Vidal, L. Ibañez, J. Laporte, 2008, The American Journal of Gastroenterology.

Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs

D. Capellà, J. Castel, J. Laporte, 2004, European Journal of Clinical Pharmacology.

Gemfibrozil-Induced Impotence

D. Capellà, J. Castel, Albert Figueras, 1993, The Annals of pharmacotherapy.

GEMFIBROZIL-INDUCED HEADACHE

J. Álvarez-Sabín, J. Laporte, A. Codina, 1988, The Lancet.

Therapeutic Ineffectiveness

Albert Figueras, Albert Figueras, J. Laporte, 2002, Drug safety.

Reporting randomised clinical trials of analgesics after traumatic or orthopaedic surgery is inadequate: a systematic review

X. Vidal, E. Montané, J. Laporte, 2010, BMC clinical pharmacology.

Systematic Review and Meta-Analysis: Macrolides- and Amoxicillin/Clavulanate-induced Acute Liver Injury.

X. Vidal, L. Ibañez, S. Schmiedl, 2016, Basic & clinical pharmacology & toxicology.

Tinnitus with calcium-channel blockers

D. Capellà, Albert Figueras, J. Laporte, 1994, The Lancet.

Prevalence of use of antipsychotic drugs in the elderly in Catalonia

J. Laporte, M. Sabaté, N. Escoda, 2018, European Journal of Clinical Pharmacology.

Gynecomastia Associated with Enalapril and Diazepam

Albert Figueras, J. Laporte, Roser Llop, 1994, The Annals of Pharmacotherapy.

The Public Health, the University, and Pharmacoepidemiology

P. Stolley, J. Laporte, 2002 .

Fatal aplastic anaemia associated with nifedipine

X. Vidal, L. Ibañez, J. Laporte, 1998, The Lancet.

Placebo effects in psychiatry

Albert Figueras, J. Laporte, 1994, The Lancet.

EFFECTS OF DIOXIN EXPOSURE

J. Laporte, 1977, The Lancet.

Cyanamide-induced aplastic anemia

L. Ibañez, J. Laporte, L. Force, 2005, European Journal of Clinical Pharmacology.

Cuba: improving use of medicines

E. Diògene, J. Laporte, V. Reggi, 1997, The Lancet.

Hypersensitivity vasculitis related to aceclofenac.

D. Capellà, R. Morros, J. Laporte, 1997, British journal of rheumatology.

Pulmonary fibrosis and amiodarone.

J. Ruiz, J. Morera, F. Morell, 1982, British medical journal.

Upper gastrointestinal bleeding associated with antiplatelet drugs

U. Moretti, X. Vidal, L. Ibañez, 2006, Alimentary pharmacology & therapeutics.

Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug

J. Laporte, E. Ballarín, E. Pérez, 2000, European Journal of Clinical Pharmacology.

Failures of the therapeutic chain as a cause of drug ineffectiveness

Albert Figueras, J. Laporte, 2003, BMJ : British Medical Journal.

Medical speciality and pattern of medicines prescription

X. Vidal, E. Montané, A. Vallano, 2004, European Journal of Clinical Pharmacology.

Interaction between Orlistat and Antihypertensive Drugs

E. F. Farías, J. Laporte, A. Figueras, 2001, The Annals of pharmacotherapy.